Alizarin 2-methyl ether
Alizarin 2-methyl ether is a DNA topoisomerase inhibitor. Alizarin 2-methyl ether inhibits the relaxation of supercoiled DNA via DNA topoisomerase I and II. Alizarin 2-methyl ether promotes adipocyte differentiation by increasing lipid accumulation. Alizarin 2-methyl ether possesses antidiabetic and insulin-sensitizing properties. Alizarin 2-methyl ether can be used in research related to human colon cancer, P-388 lymphocytic leukemia and diabetes.
For research use only. We do not sell to patients.
- CAS No.: 6003-11-8
- Formula: C15H10O4
- Molecular Weight:254.24
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Topoisomerase Isoforms
More
Biological Activity
Description
|
Topoisomerase I |
Topoisomerase II |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HT-29 | IC50 |
51.6 μM
|
Cytotoxicity against human colon carcinoma HT-29 cells measured via tetrazolium-based MTT colorimetric assay.
Cytotoxicity against human colon carcinoma HT-29 cells measured via tetrazolium-based MTT colorimetric assay.
|
18239313 |
| AGS | IC50 |
100 μM
Compound: 3B
|
Cytotoxicity against human AGS cells assessed as cell viability after 72 hrs by MTT assay
Cytotoxicity against human AGS cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 23454511] |
| MCF7 | IC50 |
>100 μM
|
Cytotoxicity against human breast carcinoma MCF-7 cells measured via tetrazolium-based MTT colorimetric assay.
Cytotoxicity against human breast carcinoma MCF-7 cells measured via tetrazolium-based MTT colorimetric assay.
|
18239313 |
| HL-60 | IC50 |
100 μM
Compound: 3B
|
Cytotoxicity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay
Cytotoxicity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 23454511] |
| HepG2 | IC50 |
>100 μM
|
Cytotoxicity against human liver carcinoma HepG2 cells measured via tetrazolium-based MTT colorimetric assay.
Cytotoxicity against human liver carcinoma HepG2 cells measured via tetrazolium-based MTT colorimetric assay.
|
18239313 |
| J82 | IC50 |
100 μM
Compound: 3B
|
Cytotoxicity against human J82 cells assessed as cell viability after 72 hrs by MTT assay
Cytotoxicity against human J82 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 23454511] |
| MRC5 | IC50 |
100 μM
Compound: 3B
|
Cytotoxicity against human MRC5 cells assessed as cell viability after 72 hrs by MTT assay
Cytotoxicity against human MRC5 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 23454511] |
| SK-MES-1 | IC50 |
100 μM
Compound: 3B
|
Cytotoxicity against human SKMES1 cells assessed as cell viability after 72 hrs by MTT assay
Cytotoxicity against human SKMES1 cells assessed as cell viability after 72 hrs by MTT assay
|
[PMID: 23454511] |
In Vitro
Alizarin 2-methyl ether (compound 8) (20-100 μM; 30 min) inhibits calf thymus DNA topoisomerase I with 75% inhibition at 100 μM and 17% inhibition at 20 μM[1].
Alizarin 2-methyl ether (20-100 μM; 30 min) inhibits human DNA topoisomerase II with 49% inhibition at 100 μM and no inhibition at 20 μM[1].
Alizarin 2-methyl ether has no significant cytotoxicity to human breast carcinoma MCF-7 cells, with an IC50 greater than 100 μM[1].
Alizarin 2-methyl ether has no significant cytotoxicity to human liver carcinoma HepG2 cells, with an IC50 greater than 100 μM[1].
Alizarin 2-methyl ether is cytotoxic to human colon carcinoma HT-29 cells with an IC50 of 51.6 μM[1].
Alizarin 2-methyl ether (compound 2) (100 μM; 8 days) enhances adipocyte differentiation in 3T3-L1 mouse preadipocytes, increasing relative fat accumulation to 131% of insulin-treated control cells[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:3T3-L1 mouse preadipocytes
-
Concentration:100 μM
-
Incubation Time:8 days
-
Result:Enhanced adipocyte differentiation, resulting in a relative fat accumulation level of 131% compared to insulin-treated control cells.
Reached statistically significant effect relative to the insulin-treated control.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 6003-11-8
-
Molecular Weight 254.24
-
Formula C15H10O4
-
SMILES
O=C1C2=C(C(C3=C(C(OC)=CC=C13)O)=O)C=CC=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
3T3-L1 preadipocyte-to-adipocyte differentiation
3T3-L1 preadipocytes are induced to differentiate after growth arrest using adipogenic media containing insulin, dexamethasone, and IBMX; differentiation is assessed by lipid-droplet accumulation, triglyceride increase, Oil Red O staining, and adipocyte-marker induction such as PPARγ and C/EBPα.
-
Large-size fat particle sorting
Large-size fat particle sorting is widely used to isolate cells up to 200 μm in diameter. Single-cell flow sorting will allow greater insight into adipocyte heterogeneity by identifying gene expression, protein composition, and metabolic signatures at the single-cell level.
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
-
Lipid Droplets: Oil Red O/Sudan Dye Lipid Staining
Lipid droplets are intracellular organelles with a neutral-lipid core that stores triacylglycerols and sterol esters, and Oil Red O or Sudan dyes detect these hydrophobic lipid deposits by partitioning into retained lipids in fresh or frozen specimens. Oil Red O stains neutral triglycerides and lipids in frozen tissue sections or air-dried cytologic preparations, while Sudan Black B has also been used as a histochemical fat stain for lipid-rich tissue structures.
Purity & Documentation
References
[1]. Son JK, et al. Anticancer constituents from the roots of Rubia cordifolia L. Chemical & pharmaceutical bulletin. 2008 Feb;56(2):213-6. [Content Brief]
[2]. Chang P, et al. Antitumor agents 50. 1 Morindaparvin-A, a new antileukemic anthraquinone, and alizarin-1-methyl ether from Morinda parvifolia, and the antileukemic activity of the related derivatives. J Nat Prod. 1982 Mar-Apr;45(2):206-10. [Content Brief]
[3]. Liu Q, et al. Anthraquinones from Morinda officinalis roots enhance adipocyte differentiation in 3T3-L1 cells. Nat Prod Res. 2012;26(18):1750-4. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)